Table 1 Baseline patient characteristics
Diprospan group (n = 30) | Placebo group (n = 30) | Control group (n = 30) | P value* | |
|---|---|---|---|---|
Male/Female, n | 26/4 | 24/6 | 27/3 | NS |
Age, yr (mean ± SD) | 67.0 ± 8.98 | 67.7 ± 9.2 | 66.4 ± 9.9 | NS |
Smokers/nonsmokers, n | 24/6 | 26/4 | 20/10 | NS |
FEV1,, % (mean ± SD) | 60.6 ± 9.5 | 62.6 ± 8.0 | 88.6 ± 7.1 | 0.001 |
LVEF, % (mean ± SD) | 46.1 ± 12.4 | 46.1 ± 11.8 | 47.8 ± 10.3 | NS |
ASA class, n | ||||
2 | 0 | 0 | 2 | |
3 | 16 | 21 | 23 | |
4 | 14 | 9 | 5 | 0.04 |